Oxea GmbH

EANS-News: Oxea GmbH
Oxea Sarl reports strong second quarter results

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
3-month report


Luxembourg (euro adhoc) - Second quarter highlights:

>> Net sales were EUR391.2 million, up 9% from the prior 
   year period
>> Operating Result was EUR46.6 million versus EUR37.9 million 
   in the prior year period
>> Net Income was EUR16.4 million versus EUR23.3 million in 
   the prior year period
>> Adjusted EBITDA was EUR56.4 million versus EUR47.2 million 
   in the prior year period
>> Completed optional redemption of 5% of Senior Secured Notes

Oxea Sarl, a leading global supplier of Oxo Intermediates and Oxo Derivatives,
today announced second quarter net sales of EUR391.2 million, an increase of 9%
compared with the corresponding period of the prior year.

Oxea´s strong performance in the second quarter once again underlines the
robustness of the business model. Continued recovery in the US and European
regions more than offset lower export sales to Asia and contributed to the
strong set of results. Operating profit at EUR46.6 million was some 23% above
the corresponding period of the prior year. Q2 2011 Adjusted EBITDA at EUR56.4
million was some 19% above the corresponding period of the prior year. Adjusted
EBITDA for the six months ended June 2011 amounted to EUR122.2 million
reflecting an increase of 49% from the corresponding period of the prior year
and underlines the continued excellent relationships with customers and the
contribution of Oxea´s employees to the success of the business. Strong cash
generation allowed Oxea to exercise an option to redeem 5% of the Senior Secured
Notes and make a payment to shareholders. After the refinancing in July 2010 net
debt has been reduced to around 2.0x Adjusted EBITDA on an LTM basis. LTM
Adjusted EBITDA now stands at EUR 218 million.


In EUR million - Unaudited 


            Three months ended    Six months ended
                    June 30,         June 30,  
                  2011    2010     2011    2010
Net Sales        391.2   357.6    768.2   647.0
Gross Profit      54.9    54.8    123.0    88.9
SG&A              (8.8)  (14.4)   (19.2)  (22.1)
R&D               (1.5)   (1.4)    (3.1)   (2.9)
Other operating 
income/(expense)   2.0    (1.1)     3.1    (1.1)
Operating Profit  46.6    37.9    103.8    62.8
Net Income        16.4    23.3     46.4    36.3

Adjusted EBITDA   56.4    47.2    122.2    81.9


Sales
Sales for the three months ended June 30, 2011 were EUR391.2 million, an
increase of 9% compared with the corresponding period of the prior year. Lower
volumes were more than offset by improved product mix and the pass through of
higher raw material costs in sales prices to customers. Overall, volumes were
some 1.1% lower than in the corresponding period of the prior year. Oxo
Intermediates volumes were some 2.8% lower than the corresponding period of the
prior year driven by production outages and lower Asian export volumes whilst
volumes in Oxo Derivatives increased by some 4.9%. Of our revenues for the three
months ended June 30, 2011, EUR212.3 million resulted from sales in Europe,
EUR116.7 million in North America and EUR62.2 million in the rest of the world
compared to EUR180.4 million, EUR99.3 million and EUR77.9 million respectively
in the prior year period.


Gross profit
Gross profit for the three months ended June 30, 2011 amounted to EUR54.9
million compared with EUR54.8 million in the corresponding period of the prior
year. The impact of lower volumes was offset by lower manufacturing fixed costs.


Selling general & administration expense (SG&A)
SG&A expense for the three months ended June 30, 2011 decreased to EUR8.8
million compared with EUR14.4 million in the corresponding period of the prior
year. The decrease is primarily attributable to higher consulting fees in
relation to projects and higher personnel costs including accruals for employee
bonuses in the second quarter of 2010.

Other operating income/(expense) *)
Net other operating income for the three months ended June 30, 2011 amounted to
EUR2.0 million compared with a net other operating expense of EUR1.1 million in
the corresponding period of the prior year. The increase is primarily
attributable to an increased income from site services.

Operating result
Operating result for the three months ended June 30, 2011 was EUR46.6 million
compared with EUR37.9 million in the corresponding period of the prior year
period as a result of lower SG&A expenses and increased income from site
services. 

Financial result *)
Net financial expense increased to EUR16.8 million compared with EUR2.1 million
in the corresponding period of the prior year primarily as a result of higher
interest expense from the refinancing in July 2010 and lower net exchange gains.

*) Prior year numbers have been adjusted to reflect the reclassification of net
foreign exchange gains and losses from other operating income to financial
result. As a result, other operating income for the quarter ended June 30, 2010
has been reduced by EUR2.8 million and net financial expense has been increased
by EUR2.8 million.

Net income
Net income was EUR16.4 million compared with EUR23.3 million in the
corresponding period of the prior year. Improved operating profit was more than
offset by increased financial expense and higher income taxes. 

Adjusted EBITDA
Adjusted EBITDA at EUR56.4 million compared with EUR47.2 million in the
corresponding period of the prior year driven by lower operating expenses and
improved other operating income. 

Cash Flow
The company continued to generate positive free cash flow and during the first
six months of 2011 Oxea generated EUR48 million in cash from operating
activities compared with EUR14 million in the corresponding period of the prior
year. Increased earnings and an improved trade working capital position were
partly offset by higher income tax payments. 

Cash used in investing activities was EUR12.5 million compared with EUR14.5
million in the corresponding period of the prior year driven by the timing of
capital expenditure. 

Cash used in financing activities was EUR104.5 million compared with EUR35.4
million in the corresponding period of the prior year driven by higher interest
payments, the optional redemption of 5% of the Senior Secured Notes and a
payment to shareholders.


Oxea is a global manufacturer of Oxo Intermediates and Derivatives such as
alcohols, polyols, carboxylic acids, specialty esters and amines. These products
are sold in the merchant market (where sales are to third party customers) and
used for the production of high-quality coatings, lubricants, cosmetic and
pharmaceutical products, flavorings and fragrances, printing inks and plastics.
In the 12 months ending June 2010, Oxea generated revenue of about EUR1.5
billion with its approximately 1,350 employees in Europe, the Americas and Asia.

Forward looking statements
* This document contains financial information regarding the businesses and
assets of OXEA S.à r.l. (the "Company") and its consolidated subsidiaries (the
"Group"). Such financial information has not been audited, reviewed or verified
by any independent accounting firm. The inclusion of such financial information
in this document or any related presentation should not be regarded as a
representation or warranty by the Company, any of its respective affiliates,
advisors or representatives or any other person as to the accuracy or
completeness of such information´s portrayal of the financial condition or
results of operations by the Group.
* This document may contain information, data and predictions about our markets
and our competitive position. While we believe this data to be reliable, it has
not been independently verified, and we make no representation or warranty as to
the accuracy or completeness of such information set forth in this document.
Additionally, industry publications and reports from which such information,
data or predictions may be obtained generally state that the information
contained therein has been obtained from sources believed to be reliable but
that the accuracy and completeness of such information is not guaranteed and in
some instances state that they do not assume liability for such information. We
cannot therefore assure you of the accuracy and completeness of such information
and we have not independently verified such information. In addition, we have
made statements in this document regarding our industry and position in the
industry based on our experience and our own investigation of market conditions.
We cannot assure you that the assumptions underlying these statements are
accurate or correctly reflect the state and development of, or our position in,
the industry, and none of our internal surveys or information has been verified
by any independent sources.
* Certain statements in this document are forward-looking. By their nature,
forward-looking statements involve known and unknown risks and uncertainties
because they relate to events and depend on circumstances that may or may not
occur in the future. Forward-looking statements are not guarantees of future
performance. These factors include, among others: the cyclical and highly
variable nature of our business and its sensitivity to changes in supply and
demand; adverse and uncertain global economic conditions; the highly variable
nature of raw materials costs and any loss of key suppliers or supply shortages
or disruptions; the competitive nature of our industry; the ability to comply
with current or future laws and regulations relating to environmental, health
and safety matters as well as the safety of our products, related costs of
maintaining compliance and addressing liabilities as well as risks relating to
compliance with antitrust and tax laws; our reliance on a limited number of
suppliers for certain of our key raw materials; operational risks, including the
risk of environmental contamination and potential product liability claims;
operational interruptions at our facilities due to events that are outside of
our control such as severe weather conditions, unscheduled downtimes, terrorist
attacks, natural disasters or other events that may interrupt or damage our
operations or the impact of scheduled outages on our results of operations; the
risk that our insurance coverage may not be sufficient to cover all risks; risks
relating to the global nature of our operations, including, among others,
fluctuations in exchange rates; the loss of major customers or key customers for
certain of our products; the loss of key personnel; risks relating to
acquisitions and dispositions, including any impairment risks with respect to
historical acquisitions, our ability to successfully integrate acquired
businesses, and unexpected liabilities relating to such acquisitions or
contingent liabilities in connection with such dispositions; the requirement to
make further contributions to our pension schemes; the failure to protect our
intellectual property rights; limitations on our ability to adjust the quality
of certain products that we manufacture; and potential conflicts of interests
with our principal shareholder.
* These and other factors could adversely affect the outcome and financial
effects of the plans and events described herein. Forward-looking statements
contained in this document regarding past trends or activities should not be
taken as a representation that such trends or activities will continue in the
future. New risks can emerge from time to time, and it is not possible for us to
predict all such risks, nor can we assess the impact of all such risks on our
business or the extent to which any risks, or combination of risks and other
factors, may cause actual results to differ materially from those contained in
any forward-looking statements. Neither the Company nor the Group undertakes any
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise. You should not place
undue reliance on forward-looking statements, which speak only as of the date of
this document.

Use of non IFRS financial information:
* EBITDA is defined as net income for the year before financial result, income
taxes, depreciation and amortization. EBITDA, is a supplemental measure of our
performance and liquidity that is not required by or presented in accordance
with IFRS. EBITDA is not a measurement of our financial performance or liquidity
under IFRS and should not be considered as an alternative to profit for the
period presented, results from operating activities or any other performance
measures derived in accordance with IFRS or as an alternative to cash flow from
operating activities as a measure of our liquidity. We believe EBITDA
facilitates operating performance comparisons from period to period and company
to company by eliminating potential differences caused by variations in capital
structures (affecting interest expense), tax positions (such as the impact on
periods or companies of change in effective tax rates or net operating losses)
and the age and book value and amortization of tangible and intangible assets
(which have an effect on related depreciation expense). We also present EBITDA
because we believe it is frequently used by securities analysts, investors and
other interested parties in the evaluation of similar issuers, the majority of
which present EBITDA when reporting their results. Finally, we present EBITDA as
a measure of our ability to service our debt. 
* Adjusted EBITDA is defined as EBITDA adjusted to remove the effects of certain
non-cash and non-recurring expenses and charges. Adjusted EBITDA is a
supplemental measure of our performance and liquidity that is not required by or
presented in accordance with IFRS. Adjusted EBITDA is not a measurement of our
financial performance or liquidity under IFRS and should not be considered as an
alternative to profit for the period presented, results from operating
activities or any other performance measures derived in accordance with IFRS or
as an alternative to cash flow from operating activities as a measure of our
liquidity. We believe Adjusted EBITDA facilitates operating performance
comparisons from period to period and company to company by eliminating certain
non-recurring expenses and charges. We also present Adjusted EBITDA because we
believe it is frequently used by securities analysts, investors and other
interested parties in the evaluation of similar issuers. Finally, we present
Adjusted EBITDA as a measure of our ability to service our debt.


Further inquiry note:
Bernhard Spetsmann
Managing Director (Finance, IT)
bernhard.spetsmann@oxea-chemicals.com

Birgit Reichel
Global Communications
birgit.reichel@oxea-chemicals.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Oxea GmbH
             Otto-Roelen-Straße 3
             D-46147 Oberhausen
phone:       +49(0)208 693 3112
FAX:         +49(0)208 693 3101
mail:     birgit.reichel@oxea-chemicals.com
WWW:      http://www.oxea-chemicals.com
sector:      Chemicals
ISIN:        XS0523636594
indexes:     
stockmarkets: Open Market: Frankfurt 
language:   English
 



Weitere Meldungen: Oxea GmbH

Das könnte Sie auch interessieren: